By Aparajita Lath
Some COVID-19 vaccine manufacturers in the US have refused to share vaccine samples for research purposes, creating an access issue with the potential to delay comparator studies, follow-on research, and new vaccine / drug development.
This issue may be the latest example of the tragedy of the “anticommons” in biomedical research.